Fujian University of Traditional Chinese Medicine in China has reported that repetitive transcranial magnetic stimulation ...

CMD patients face a 2x higher risk of dementia and MCI, but healthier lifestyles can counter air pollution's impact and ...

A novel tool known as the Florey Dementia Index (FDI) predicted onset age of mild cognitive impairment or Alzheimer's disease ...

Results of the HOPE4MCI trial to date provide strong ... including clinical and non-clinical stage products, and the key mild cognitive impairment companies, including Alzheon Inc., ...

New research suggests a statistical model may accurately predict onset of mild cognitive impairment and Alzheimer ... of the participant as well as the Clinical Dementia Rating Sum of Boxes ...

Mild cognitive impairment (MCI) refers to a noticeable decline in cognitive abilities, such as memory and thinking, that is more severe than expected for a person's age but not severe enough to ...

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

SAN FRANCISCO, CALIFORNIA / ACCESSWIRE / January 13, 2025 / TheraVac Biologics (TheraVac), a company developing innovative immunotherapies for neurological and autoimmune disease, is thrilled to annou ...

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

Mild Cognitive Impairment Epidemiology Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the mild cognitive impairment ...

Mild Cognitive Impairment Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products ...